Your browser doesn't support javascript.
Determinants of Vaccination and Willingness to Vaccinate against COVID-19 among Pregnant and Postpartum Women during the Third Wave of the Pandemic: A European Multinational Cross-Sectional Survey.
Maisonneuve, Emeline; Gerbier, Eva; Tauqeer, Fatima; Pomar, Léo; Favre, Guillaume; Winterfeld, Ursula; Passier, Anneke; Oliver, Alison; Baud, David; Nordeng, Hedvig; Ceulemans, Michael; Panchaud, Alice.
  • Maisonneuve E; Institute of Primary Health Care (BIHAM), University of Bern, 3012 Bern, Switzerland.
  • Gerbier E; Materno-Fetal and Obstetrics Research Unit, Department "Femme-Mère-Enfant", Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Tauqeer F; Service of Pharmacy, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Pomar L; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.
  • Favre G; Materno-Fetal and Obstetrics Research Unit, Department "Femme-Mère-Enfant", Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Winterfeld U; School of Health Sciences (HESAV), University of Applied Sciences and Arts Western Switzerland, 1011 Lausanne, Switzerland.
  • Passier A; Materno-Fetal and Obstetrics Research Unit, Department "Femme-Mère-Enfant", Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Oliver A; Swiss Teratogen Information Service, Clinical pharmacology Service, Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Baud D; Teratology Information Service, Pharmacovigilance Centre Lareb, 5237 MH 's Hertogenbosch, The Netherlands.
  • Nordeng H; UK Teratology Information Service, Newcastle upon Tyne Hospitals, NHS Foundation Trust and the UK Health Security Agency, Newcastle upon Tynes NE2 4AB, UK.
  • Ceulemans M; Materno-Fetal and Obstetrics Research Unit, Department "Femme-Mère-Enfant", Lausanne University Hospital and University of Lausanne, 1011 Lausanne, Switzerland.
  • Panchaud A; Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Strategic Research Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, 0316 Oslo, Norway.
Viruses ; 15(5)2023 04 29.
Artículo en Inglés | MEDLINE | ID: covidwho-20239141
ABSTRACT
With COVID-19 vaccination hesitancy at around 50% in the obstetric population, it is critical to identify which women should be addressed and how. Our study aimed to assess COVID-19 vaccination willingness among pregnant and postpartum women in Europe and to investigate associated determinants. This study was a cross-sectional, web-based survey conducted in Belgium, Norway, Switzerland, The Netherlands, and United Kingdom (UK) in June-August 2021. Among 3194 pregnant women, the proportions of women vaccinated or willing to be vaccinated ranged from 80.5% in Belgium to 21.5% in Norway. The associated characteristics were country of residence, chronic illness, history of flu vaccine, trimester of pregnancy, belief that COVID-19 is more severe during pregnancy, and belief that the COVID-19 vaccine is effective and safe during pregnancy. Among 1659 postpartum women, the proportions of women vaccinated or willing to be vaccinated ranged from 86.0% in the UK to 58.6% in Switzerland. The associated determinants were country of residence, chronic illness, history of flu vaccine, breastfeeding, and belief that the COVID-19 vaccine is safe during breastfeeding. Vaccine hesitancy in the obstetric population depends on medical history and especially on the opinion that the vaccine is safe and on the country of residence.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / COVID-19 Tipo de estudio: Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Femenino / Humanos / Embarazo Idioma: Inglés Año: 2023 Tipo del documento: Artículo País de afiliación: V15051090

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / COVID-19 Tipo de estudio: Estudio observacional / Estudio pronóstico / Ensayo controlado aleatorizado Tópicos: Vacunas Límite: Femenino / Humanos / Embarazo Idioma: Inglés Año: 2023 Tipo del documento: Artículo País de afiliación: V15051090